(3aR,6aS)-N-(3-acetylpyrazin-2-yl)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide;(3aR,6aS)-N-(5-acetylpyridazin-4-yl)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide;bis((3aR,6aS)-N-(4,6-dimethylpyrimidin-2-yl)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide);[(3aR,6aS)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]-(4,6-dimethylpyrimidin-2-yl)methanone;methyl 2-[(3aS,6aR)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carbonyl]-6-methylpyrimidine-4-carboxylate

C127H132F18N22O10 — CID 158232038

IUPAC(3aR,6aS)-N-(3-acetylpyrazin-2-yl)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide;(3aR,6aS)-N-(5-acetylpyridazin-4-yl)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide;bis((3aR,6aS)-N-(4,6-dimethylpyrimidin-2-yl)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide);[(3aR,6aS)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]-(4,6-dimethylpyrimidin-2-yl)methanone;methyl 2-[(3aS,6aR)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carbonyl]-6-methylpyrimidine-4-carboxylate
SMILESCC(=O)c1cnncc1NC(=O)N1C[C@H]2CC(c3ccccc3C(F)(F)F)C[C@H]2C1.CC(=O)c1nccnc1NC(=O)N1C[C@H]2CC(c3ccccc3C(F)(F)F)C[C@H]2C1.COC(=O)c1cc(C)nc(C(=O)N2C[C@H]3CC(c4ccccc4C(F)(F)F)C[C@H]3C2)n1.Cc1cc(C)nc(C(=O)N2C[C@H]3CC(c4ccccc4C(F)(F)F)C[C@H]3C2)n1.Cc1cc(C)nc(NC(=O)N2C[C@H]3CC(c4ccccc4C(F)(F)F)C[C@H]3C2)n1.Cc1cc(C)nc(NC(=O)N2C[C@H]3CC(c4ccccc4C(F)(F)F)C[C@H]3C2)n1
InChIInChI=1S/C22H22F3N3O3.2C21H21F3N4O2.2C21H23F3N4O.C21H22F3N3O/c1-12-7-18(21(30)31-2)27-19(26-12)20(29)28-10-14-8-13(9-15(14)11-28)16-5-3-4-6-17(16)22(23,24)25;1-12(29)17-8-25-26-9-19(17)27-20(30)28-10-14-6-13(7-15(14)11-28)16-4-2-3-5-18(16)21(22,23)24;1-12(29)18-19(26-7-6-25-18)27-20(30)28-10-14-8-13(9-15(14)11-28)16-4-2-3-5-17(16)21(22,23)24;2*1-12-7-13(2)26-19(25-12)27-20(29)28-10-15-8-14(9-16(15)11-28)17-5-3-4-6-18(17)21(22,23)24;1-12-7-13(2)26-19(25-12)20(28)27-10-15-8-14(9-16(15)11-27)17-5-3-4-6-18(17)21(22,23)24/h3-7,13-15H,8-11H2,1-2H3;2-5,8-9,13-15H,6-7,10-11H2,1H3,(H,25,27,30);2-7,13-15H,8-11H2,1H3,(H,26,27,30);2*3-7,14-16H,8-11H2,1-2H3,(H,25,26,27,29);3-7,14-16H,8-11H2,1-2H3/t3*13?,14-,15+;3*14?,15-,16+
InChIKeyGEMMUXNKUGNZDD-PQXYRTHKSA-N
MW2468.56 g/mol
LogP26.48
Rot. Bonds15

About (3aR,6aS)-N-(3-acetylpyrazin-2-yl)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide;(3aR,6aS)-N-(5-acetylpyridazin-4-yl)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide;bis((3aR,6aS)-N-(4,6-dimethylpyrimidin-2-yl)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide);[(3aR,6aS)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]-(4,6-dimethylpyrimidin-2-yl)methanone;methyl 2-[(3aS,6aR)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carbonyl]-6-methylpyrimidine-4-carboxylate

(3aR,6aS)-N-(3-acetylpyrazin-2-yl)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide;(3aR,6aS)-N-(5-acetylpyridazin-4-yl)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide;bis((3aR,6aS)-N-(4,6-dimethylpyrimidin-2-yl)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide);[(3aR,6aS)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]-(4,6-dimethylpyrimidin-2-yl)methanone;methyl 2-[(3aS,6aR)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carbonyl]-6-methylpyrimidine-4-carboxylate (PubChem CID 158232038) has the molecular formula C127H132F18N22O10 and a molecular weight of 2468.56 g/mol. Its IUPAC name is (3aR,6aS)-N-(3-acetylpyrazin-2-yl)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide;(3aR,6aS)-N-(5-acetylpyridazin-4-yl)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide;bis((3aR,6aS)-N-(4,6-dimethylpyrimidin-2-yl)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide);[(3aR,6aS)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]-(4,6-dimethylpyrimidin-2-yl)methanone;methyl 2-[(3aS,6aR)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carbonyl]-6-methylpyrimidine-4-carboxylate.

Molecular Properties

Compound Name(3aR,6aS)-N-(3-acetylpyrazin-2-yl)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide;(3aR,6aS)-N-(5-acetylpyridazin-4-yl)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide;bis((3aR,6aS)-N-(4,6-dimethylpyrimidin-2-yl)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide);[(3aR,6aS)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]-(4,6-dimethylpyrimidin-2-yl)methanone;methyl 2-[(3aS,6aR)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carbonyl]-6-methylpyrimidine-4-carboxylate
PubChem CID158232038
Molecular FormulaC127H132F18N22O10
Molecular Weight2468.56 g/mol
Exact Mass2467.02
IUPAC Name(3aR,6aS)-N-(3-acetylpyrazin-2-yl)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide;(3aR,6aS)-N-(5-acetylpyridazin-4-yl)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide;bis((3aR,6aS)-N-(4,6-dimethylpyrimidin-2-yl)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide);[(3aR,6aS)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]-(4,6-dimethylpyrimidin-2-yl)methanone;methyl 2-[(3aS,6aR)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carbonyl]-6-methylpyrimidine-4-carboxylate
SMILESCC(=O)c1cnncc1NC(=O)N1C[C@H]2CC(c3ccccc3C(F)(F)F)C[C@H]2C1.CC(=O)c1nccnc1NC(=O)N1C[C@H]2CC(c3ccccc3C(F)(F)F)C[C@H]2C1.COC(=O)c1cc(C)nc(C(=O)N2C[C@H]3CC(c4ccccc4C(F)(F)F)C[C@H]3C2)n1.Cc1cc(C)nc(C(=O)N2C[C@H]3CC(c4ccccc4C(F)(F)F)C[C@H]3C2)n1.Cc1cc(C)nc(NC(=O)N2C[C@H]3CC(c4ccccc4C(F)(F)F)C[C@H]3C2)n1.Cc1cc(C)nc(NC(=O)N2C[C@H]3CC(c4ccccc4C(F)(F)F)C[C@H]3C2)n1
InChIInChI=1S/C22H22F3N3O3.2C21H21F3N4O2.2C21H23F3N4O.C21H22F3N3O/c1-12-7-18(21(30)31-2)27-19(26-12)20(29)28-10-14-8-13(9-15(14)11-28)16-5-3-4-6-17(16)22(23,24)25;1-12(29)17-8-25-26-9-19(17)27-20(30)28-10-14-6-13(7-15(14)11-28)16-4-2-3-5-18(16)21(22,23)24;1-12(29)18-19(26-7-6-25-18)27-20(30)28-10-14-8-13(9-15(14)11-28)16-4-2-3-5-17(16)21(22,23)24;2*1-12-7-13(2)26-19(25-12)27-20(29)28-10-15-8-14(9-16(15)11-28)17-5-3-4-6-18(17)21(22,23)24;1-12-7-13(2)26-19(25-12)20(28)27-10-15-8-14(9-16(15)11-27)17-5-3-4-6-18(17)21(22,23)24/h3-7,13-15H,8-11H2,1-2H3;2-5,8-9,13-15H,6-7,10-11H2,1H3,(H,25,27,30);2-7,13-15H,8-11H2,1H3,(H,26,27,30);2*3-7,14-16H,8-11H2,1-2H3,(H,25,26,27,29);3-7,14-16H,8-11H2,1-2H3/t3*13?,14-,15+;3*14?,15-,16+
InChIKeyGEMMUXNKUGNZDD-PQXYRTHKSA-N
XLogP26.48
TPSA385.10 Ų
H-Bond Donors4
H-Bond Acceptors22
Rotatable Bonds15
Heavy Atoms177
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002468.56
LogP ≤ 526.48
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1022

Analyze (3aR,6aS)-N-(3-acetylpyrazin-2-yl)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide;(3aR,6aS)-N-(5-acetylpyridazin-4-yl)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide;bis((3aR,6aS)-N-(4,6-dimethylpyrimidin-2-yl)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide);[(3aR,6aS)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]-(4,6-dimethylpyrimidin-2-yl)methanone;methyl 2-[(3aS,6aR)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carbonyl]-6-methylpyrimidine-4-carboxylate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (3aR,6aS)-N-(3-acetylpyrazin-2-yl)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide;(3aR,6aS)-N-(5-acetylpyridazin-4-yl)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide;bis((3aR,6aS)-N-(4,6-dimethylpyrimidin-2-yl)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide);[(3aR,6aS)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]-(4,6-dimethylpyrimidin-2-yl)methanone;methyl 2-[(3aS,6aR)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carbonyl]-6-methylpyrimidine-4-carboxylate?
The IUPAC name of (3aR,6aS)-N-(3-acetylpyrazin-2-yl)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide;(3aR,6aS)-N-(5-acetylpyridazin-4-yl)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide;bis((3aR,6aS)-N-(4,6-dimethylpyrimidin-2-yl)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide);[(3aR,6aS)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]-(4,6-dimethylpyrimidin-2-yl)methanone;methyl 2-[(3aS,6aR)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carbonyl]-6-methylpyrimidine-4-carboxylate (CID 158232038) is (3aR,6aS)-N-(3-acetylpyrazin-2-yl)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide;(3aR,6aS)-N-(5-acetylpyridazin-4-yl)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide;bis((3aR,6aS)-N-(4,6-dimethylpyrimidin-2-yl)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide);[(3aR,6aS)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]-(4,6-dimethylpyrimidin-2-yl)methanone;methyl 2-[(3aS,6aR)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carbonyl]-6-methylpyrimidine-4-carboxylate.
What is the SMILES notation for (3aR,6aS)-N-(3-acetylpyrazin-2-yl)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide;(3aR,6aS)-N-(5-acetylpyridazin-4-yl)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide;bis((3aR,6aS)-N-(4,6-dimethylpyrimidin-2-yl)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide);[(3aR,6aS)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]-(4,6-dimethylpyrimidin-2-yl)methanone;methyl 2-[(3aS,6aR)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carbonyl]-6-methylpyrimidine-4-carboxylate?
The canonical SMILES for (3aR,6aS)-N-(3-acetylpyrazin-2-yl)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide;(3aR,6aS)-N-(5-acetylpyridazin-4-yl)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide;bis((3aR,6aS)-N-(4,6-dimethylpyrimidin-2-yl)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide);[(3aR,6aS)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]-(4,6-dimethylpyrimidin-2-yl)methanone;methyl 2-[(3aS,6aR)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carbonyl]-6-methylpyrimidine-4-carboxylate is CC(=O)c1cnncc1NC(=O)N1C[C@H]2CC(c3ccccc3C(F)(F)F)C[C@H]2C1.CC(=O)c1nccnc1NC(=O)N1C[C@H]2CC(c3ccccc3C(F)(F)F)C[C@H]2C1.COC(=O)c1cc(C)nc(C(=O)N2C[C@H]3CC(c4ccccc4C(F)(F)F)C[C@H]3C2)n1.Cc1cc(C)nc(C(=O)N2C[C@H]3CC(c4ccccc4C(F)(F)F)C[C@H]3C2)n1.Cc1cc(C)nc(NC(=O)N2C[C@H]3CC(c4ccccc4C(F)(F)F)C[C@H]3C2)n1.Cc1cc(C)nc(NC(=O)N2C[C@H]3CC(c4ccccc4C(F)(F)F)C[C@H]3C2)n1.
What is the InChIKey of (3aR,6aS)-N-(3-acetylpyrazin-2-yl)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide;(3aR,6aS)-N-(5-acetylpyridazin-4-yl)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide;bis((3aR,6aS)-N-(4,6-dimethylpyrimidin-2-yl)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide);[(3aR,6aS)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]-(4,6-dimethylpyrimidin-2-yl)methanone;methyl 2-[(3aS,6aR)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carbonyl]-6-methylpyrimidine-4-carboxylate?
The InChIKey is GEMMUXNKUGNZDD-PQXYRTHKSA-N. The full InChI is InChI=1S/C22H22F3N3O3.2C21H21F3N4O2.2C21H23F3N4O.C21H22F3N3O/c1-12-7-18(21(30)31-2)27-19(26-12)20(29)28-10-14-8-13(9-15(14)11-28)16-5-3-4-6-17(16)22(23,24)25;1-12(29)17-8-25-26-9-19(17)27-20(30)28-10-14-6-13(7-15(14)11-28)16-4-2-3-5-18(16)21(22,23)24;1-12(29)18-19(26-7-6-25-18)27-20(30)28-10-14-8-13(9-15(14)11-28)16-4-2-3-5-17(16)21(22,23)24;2*1-12-7-13(2)26-19(25-12)27-20(29)28-10-15-8-14(9-16(15)11-28)17-5-3-4-6-18(17)21(22,23)24;1-12-7-13(2)26-19(25-12)20(28)27-10-15-8-14(9-16(15)11-27)17-5-3-4-6-18(17)21(22,23)24/h3-7,13-15H,8-11H2,1-2H3;2-5,8-9,13-15H,6-7,10-11H2,1H3,(H,25,27,30);2-7,13-15H,8-11H2,1H3,(H,26,27,30);2*3-7,14-16H,8-11H2,1-2H3,(H,25,26,27,29);3-7,14-16H,8-11H2,1-2H3/t3*13?,14-,15+;3*14?,15-,16+.
What are the key properties of (3aR,6aS)-N-(3-acetylpyrazin-2-yl)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide;(3aR,6aS)-N-(5-acetylpyridazin-4-yl)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide;bis((3aR,6aS)-N-(4,6-dimethylpyrimidin-2-yl)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide);[(3aR,6aS)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]-(4,6-dimethylpyrimidin-2-yl)methanone;methyl 2-[(3aS,6aR)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carbonyl]-6-methylpyrimidine-4-carboxylate?
(3aR,6aS)-N-(3-acetylpyrazin-2-yl)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide;(3aR,6aS)-N-(5-acetylpyridazin-4-yl)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide;bis((3aR,6aS)-N-(4,6-dimethylpyrimidin-2-yl)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide);[(3aR,6aS)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]-(4,6-dimethylpyrimidin-2-yl)methanone;methyl 2-[(3aS,6aR)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carbonyl]-6-methylpyrimidine-4-carboxylate has a molecular weight of 2468.56 g/mol, XLogP of 26.48, 15 rotatable bonds, 4 hydrogen bond donors, and 22 hydrogen bond acceptors.
Where does this data come from?
All data for (3aR,6aS)-N-(3-acetylpyrazin-2-yl)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide;(3aR,6aS)-N-(5-acetylpyridazin-4-yl)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide;bis((3aR,6aS)-N-(4,6-dimethylpyrimidin-2-yl)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide);[(3aR,6aS)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]-(4,6-dimethylpyrimidin-2-yl)methanone;methyl 2-[(3aS,6aR)-5-[2-(trifluoromethyl)phenyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carbonyl]-6-methylpyrimidine-4-carboxylate is sourced from PubChem (CID 158232038), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).